130 related articles for article (PubMed ID: 34974464)
41. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.
Jun CH; Hong HJ; Chung MW; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
World J Gastroenterol; 2013 Oct; 19(40):6834-41. PubMed ID: 24187458
[TBL] [Abstract][Full Text] [Related]
42. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.
Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y
Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029
[TBL] [Abstract][Full Text] [Related]
43. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
44. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
45. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
Kang SH; Kim DY; Jeon SM; Ahn SH; Park JY; Kim SU; Kim JK; Lee KS; Chon CY; Han KH
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):849-56. PubMed ID: 22495400
[TBL] [Abstract][Full Text] [Related]
47. Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.
Li L; Chen J; Xu W; Ding X; Wang X; Liang J
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e336-e340. PubMed ID: 29071776
[TBL] [Abstract][Full Text] [Related]
48. [Paraneoplastic syndrome of hepatocellular carcinoma].
Tagawa K; Uta Y
Ryoikibetsu Shokogun Shirizu; 1995; (7):453-5. PubMed ID: 8749523
[No Abstract] [Full Text] [Related]
49. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
[TBL] [Abstract][Full Text] [Related]
50. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis.
Risaliti M; Bartolini I; Campani C; Arena U; Xodo C; Adotti V; Rosi M; Taddei A; Muiesan P; Amedei A; Batignani G; Marra F
World J Gastroenterol; 2022 Aug; 28(29):3981-3993. PubMed ID: 36157535
[TBL] [Abstract][Full Text] [Related]
51. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
52. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
53. [The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].
Ko YS; Bae JH; Sinn DH; Gwak GY; Kang W; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Korean J Gastroenterol; 2017 Apr; 69(4):232-238. PubMed ID: 28449425
[TBL] [Abstract][Full Text] [Related]
54. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
55. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of clinicopathological features and prognosis between alpha-fetoprotein negative and positive hepatocellular carcinoma patients after R0 radical hepatectomy].
Songlin A; Weiqi R; Liming W; Fan W; Weibo Y; Li F; Faqiang L; Fei T; Chao B; Jianxiong W
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):308-11. PubMed ID: 26462898
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272
[TBL] [Abstract][Full Text] [Related]
58. Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients.
Ge J; Zhang X; Zhang B; Zhu L; Zhao M; Gao W; Chen D
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101573. PubMed ID: 33281070
[TBL] [Abstract][Full Text] [Related]
59. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Ikai I; Arii S; Kojiro M; Ichida T; Makuuchi M; Matsuyama Y; Nakanuma Y; Okita K; Omata M; Takayasu K; Yamaoka Y
Cancer; 2004 Aug; 101(4):796-802. PubMed ID: 15305412
[TBL] [Abstract][Full Text] [Related]
60. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]